White Male Children at Highest Risk for Color Blindness

Published Online: Thursday, May 15, 2014
Follow Pharmacy_Times:
White male children are the most likely to be diagnosed with color blindness compared with children of other ethnicities, the results of a recent study suggest.

The population-based, cross-sectional study, published online on April 3, 2014, in Ophthalmology, was part of the Multi-Ethnic Pediatric Eye Disease Study and evaluated the prevalence of color vision deficiency based on gender and ethnicity among preschool-aged children. A total of 4177 children were able to complete color vision testing and were separated into 4 ethnic groups: black, Asian, Hispanic, or non-Hispanic white. The researchers of the study also analyzed at which age children could be effectively screened for color blindness.

The results indicated that boys were significantly more likely than girls to be color blind, and that white male children were at the highest risk. The analysis found that 5.6% of non-Hispanic white male children were color blind, compared with 3.1% of Asian, 2.6% of Hispanic, and 1.4% of black male children. The prevalence of color blindness among boys was significantly different between black and white children and between Hispanic and white children. Overall, 32% of color blind cases among boys were classified as mild, 15% as moderate, and 41% as severe. The prevalence of color blindness among girls ranged from 0% to 0.5% among all ethnic groups. The results also indicated that testability for color vision deficiency is high when children are 4 years of age.

Related Articles
Children with attention-deficit/hyperactivity disorder may be more at risk for binge eating than their peers.
Even though kids with neurological disorders are at high risk for flu-related complications, they are no more likely to receive annual flu vaccination than healthy children.
Energy drink overconsumption has dangerous cardiac and neurologic consequences in adolescents.
Even though Shire is seeking an adult indication for its investigational ADHD treatment, the FDA is requesting pediatric data before deliberating the drug’s approval.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$